Post Script on “Right Rebate” Law

As expected, Donald Trump has signed the Medicaid Services Investment and Accountability Act of 2019 (H.R. 1839), which, among other things, amends the Medicaid Drug Rebate statute to impose penalties for misclassifying innovator drugs as non-innovator drugs to reduce rebates.  We previously posted on this law when it passed the Congress on April 2 (see our previous post here).  The law is effective as of April 18, the date of enactment.